LAROTRECTINIB vs LASMIDITAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAROTRECTINIB vs LASMIDITAN: Safety Overview
| Metric | LAROTRECTINIB | LASMIDITAN |
|---|---|---|
| Total FAERS Reports | 798 | 927 |
| Deaths Reported | 149 | 12 |
| Death Rate | 18.7% | 1.3% |
| Hospitalizations | 151 | 23 |
| Average Patient Age | 48.9 yrs | 47.0 yrs |
| % Female Patients | 51.5% | 85.4% |
| FDA Approval Date | Nov 26, 2018 | Dec 18, 2020 |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. | Eli Lilly and Company |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |